Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization

Der Chong Tsai, Min J. Charng, Fenq L. Lee, Wen-Ming Hsu, Shih J. Chen

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Because the blood flow is much more intense in the choroid than in the retina, it is interesting to explore whether choroidal neovascularization (CNV) is more influenced by plasma angiogenic factors than retinal neovascularization. The aim of this study was to investigate plasma profiles of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients with CNV due to age-related macular degeneration (AMD) and in those with retinal neovascularization due to proliferative diabetic retinopathy (PDR). Seventy-seven subjects with AMD, 22 with PDR, and 42 nondiabetic, non-AMD controls were enrolled in this comparative case series. AMD subjects were classified into three groups: dry type (dry AMD, n = 17), wet type with active CNV (CNV/AMD, n = 42), and disciform scar due to advanced wet AMD (scar/AMD, n = 18). Plasma VEGF and NO levels of each subject were measured with enzyme-linked immunosorbent assay and chemiluminescence, respectively. Plasma VEGF level in CNV/AMD (median 256.0 pg/ml, interquartile range 146.4-375.3 pg/ml) was significantly higher than in PDR (124.8 pg/ml, 75.7-215.3 pg/ml; p = 0.004) and controls (120.3 pg/ml, 82.8-168.2 pg/ml, p = 0.001). CNV/AMD also had the highest VEGF level among the AMD subgroups. Plasma NO level was significantly elevated in PDR (137.4 μM, 63.7-240.1 μM) when compared with CNV/ AMD (71.8 μM, 42.4-113.3 μM; p = 0.004) and controls (62.6 μM, 39.0-114.9 μM; p = 0.002). There was no significant difference in NO levels among the AMD subgroups. No significant correlation between VEGF and NO levels was noted. These findings indicate that both circulating VEGF and NO may play different roles in the pathogenesis of retinal neovascularization and CNV.

Original languageEnglish
Pages (from-to)246-251
Number of pages6
JournalOphthalmologica
Volume220
Issue number4
DOIs
Publication statusPublished - Jun 1 2006
Externally publishedYes

Fingerprint

Retinal Neovascularization
Choroidal Neovascularization
Macular Degeneration
Vascular Endothelial Growth Factor A
Nitric Oxide
Diabetic Retinopathy
Cicatrix
Choroid
Angiogenesis Inducing Agents
Luminescence

Keywords

  • Age-related macular degeneration
  • Choroidal neovascularization
  • Nitric oxide
  • Proliferative diabetic retinopathy
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. / Tsai, Der Chong; Charng, Min J.; Lee, Fenq L.; Hsu, Wen-Ming; Chen, Shih J.

In: Ophthalmologica, Vol. 220, No. 4, 01.06.2006, p. 246-251.

Research output: Contribution to journalArticle

@article{b4dd8e8912ff4972bcfe99d89a745c11,
title = "Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization",
abstract = "Because the blood flow is much more intense in the choroid than in the retina, it is interesting to explore whether choroidal neovascularization (CNV) is more influenced by plasma angiogenic factors than retinal neovascularization. The aim of this study was to investigate plasma profiles of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients with CNV due to age-related macular degeneration (AMD) and in those with retinal neovascularization due to proliferative diabetic retinopathy (PDR). Seventy-seven subjects with AMD, 22 with PDR, and 42 nondiabetic, non-AMD controls were enrolled in this comparative case series. AMD subjects were classified into three groups: dry type (dry AMD, n = 17), wet type with active CNV (CNV/AMD, n = 42), and disciform scar due to advanced wet AMD (scar/AMD, n = 18). Plasma VEGF and NO levels of each subject were measured with enzyme-linked immunosorbent assay and chemiluminescence, respectively. Plasma VEGF level in CNV/AMD (median 256.0 pg/ml, interquartile range 146.4-375.3 pg/ml) was significantly higher than in PDR (124.8 pg/ml, 75.7-215.3 pg/ml; p = 0.004) and controls (120.3 pg/ml, 82.8-168.2 pg/ml, p = 0.001). CNV/AMD also had the highest VEGF level among the AMD subgroups. Plasma NO level was significantly elevated in PDR (137.4 μM, 63.7-240.1 μM) when compared with CNV/ AMD (71.8 μM, 42.4-113.3 μM; p = 0.004) and controls (62.6 μM, 39.0-114.9 μM; p = 0.002). There was no significant difference in NO levels among the AMD subgroups. No significant correlation between VEGF and NO levels was noted. These findings indicate that both circulating VEGF and NO may play different roles in the pathogenesis of retinal neovascularization and CNV.",
keywords = "Age-related macular degeneration, Choroidal neovascularization, Nitric oxide, Proliferative diabetic retinopathy, Vascular endothelial growth factor",
author = "Tsai, {Der Chong} and Charng, {Min J.} and Lee, {Fenq L.} and Wen-Ming Hsu and Chen, {Shih J.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1159/000093079",
language = "English",
volume = "220",
pages = "246--251",
journal = "Ophthalmologica",
issn = "0030-3755",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization

AU - Tsai, Der Chong

AU - Charng, Min J.

AU - Lee, Fenq L.

AU - Hsu, Wen-Ming

AU - Chen, Shih J.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Because the blood flow is much more intense in the choroid than in the retina, it is interesting to explore whether choroidal neovascularization (CNV) is more influenced by plasma angiogenic factors than retinal neovascularization. The aim of this study was to investigate plasma profiles of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients with CNV due to age-related macular degeneration (AMD) and in those with retinal neovascularization due to proliferative diabetic retinopathy (PDR). Seventy-seven subjects with AMD, 22 with PDR, and 42 nondiabetic, non-AMD controls were enrolled in this comparative case series. AMD subjects were classified into three groups: dry type (dry AMD, n = 17), wet type with active CNV (CNV/AMD, n = 42), and disciform scar due to advanced wet AMD (scar/AMD, n = 18). Plasma VEGF and NO levels of each subject were measured with enzyme-linked immunosorbent assay and chemiluminescence, respectively. Plasma VEGF level in CNV/AMD (median 256.0 pg/ml, interquartile range 146.4-375.3 pg/ml) was significantly higher than in PDR (124.8 pg/ml, 75.7-215.3 pg/ml; p = 0.004) and controls (120.3 pg/ml, 82.8-168.2 pg/ml, p = 0.001). CNV/AMD also had the highest VEGF level among the AMD subgroups. Plasma NO level was significantly elevated in PDR (137.4 μM, 63.7-240.1 μM) when compared with CNV/ AMD (71.8 μM, 42.4-113.3 μM; p = 0.004) and controls (62.6 μM, 39.0-114.9 μM; p = 0.002). There was no significant difference in NO levels among the AMD subgroups. No significant correlation between VEGF and NO levels was noted. These findings indicate that both circulating VEGF and NO may play different roles in the pathogenesis of retinal neovascularization and CNV.

AB - Because the blood flow is much more intense in the choroid than in the retina, it is interesting to explore whether choroidal neovascularization (CNV) is more influenced by plasma angiogenic factors than retinal neovascularization. The aim of this study was to investigate plasma profiles of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in patients with CNV due to age-related macular degeneration (AMD) and in those with retinal neovascularization due to proliferative diabetic retinopathy (PDR). Seventy-seven subjects with AMD, 22 with PDR, and 42 nondiabetic, non-AMD controls were enrolled in this comparative case series. AMD subjects were classified into three groups: dry type (dry AMD, n = 17), wet type with active CNV (CNV/AMD, n = 42), and disciform scar due to advanced wet AMD (scar/AMD, n = 18). Plasma VEGF and NO levels of each subject were measured with enzyme-linked immunosorbent assay and chemiluminescence, respectively. Plasma VEGF level in CNV/AMD (median 256.0 pg/ml, interquartile range 146.4-375.3 pg/ml) was significantly higher than in PDR (124.8 pg/ml, 75.7-215.3 pg/ml; p = 0.004) and controls (120.3 pg/ml, 82.8-168.2 pg/ml, p = 0.001). CNV/AMD also had the highest VEGF level among the AMD subgroups. Plasma NO level was significantly elevated in PDR (137.4 μM, 63.7-240.1 μM) when compared with CNV/ AMD (71.8 μM, 42.4-113.3 μM; p = 0.004) and controls (62.6 μM, 39.0-114.9 μM; p = 0.002). There was no significant difference in NO levels among the AMD subgroups. No significant correlation between VEGF and NO levels was noted. These findings indicate that both circulating VEGF and NO may play different roles in the pathogenesis of retinal neovascularization and CNV.

KW - Age-related macular degeneration

KW - Choroidal neovascularization

KW - Nitric oxide

KW - Proliferative diabetic retinopathy

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=33745445207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745445207&partnerID=8YFLogxK

U2 - 10.1159/000093079

DO - 10.1159/000093079

M3 - Article

C2 - 16785756

AN - SCOPUS:33745445207

VL - 220

SP - 246

EP - 251

JO - Ophthalmologica

JF - Ophthalmologica

SN - 0030-3755

IS - 4

ER -